aTyr Pharma Inc (NASDAQ:LIFE)

0.915
Delayed Data
As of May 23
 +0.005 / +0.55%
Today’s Change
0.80
Today|||52-Week Range
6.50
-73.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$46.2M

Company Description

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler in 2005 and is headquartered in San Diego, CA.

Contact Information

aTyr Pharma, Inc.
3545 John Hopkins Court
San Diego California 92121
P:(858) 731-8389
Investor Relations:
(858) 223-1163

Employees

Shareholders

Mutual fund holders9.30%
Individual stakeholders49.04%
Other institutional29.76%

Top Executives

Sanjay S. ShuklaPresident, Chief Executive Officer & Director
Stan BlackburnChief Financial & Accounting Officer
David John KingChief Scientific Officer
Andrew B. CubittVice President-External Scientific Alliances
Ashraf AmanullahSenior VP-Biologics Development & Manufacturing